Vol 83, No 2 (2025)
Letter to the Editor
Published online: 2024-12-23
Transcatheter aortic valve implantation in young patients: Why, for what?
Abstract
Not available
References
- Sternalski T, Trębacz J, Sobczyński R, et al. Symptomatic aortic regurgitation treated by transcatheter aortic valve implantation in young patients with congenital aortic stenosis. Pol Heart J. 2024.
- Muratori M, Fusini L, Tamborini G, et al. Mitral valve regurgitation in patients undergoing TAVI: Impact of severity and etiology on clinical outcome. Int J Cardiol. 2020; 299: 228–234.
- Brunner N, de Jesus Perez VA, Richter A, et al. Perioperative pharmacological management of pulmonary hypertensive crisis during congenital heart surgery. Pulm Circ. 2014; 4(1): 10–24.
- Imamura Y, Kowatari R, Koizumi J, et al. Twenty-year experience following aortic valve replacement in patients younger than 60 years of age. J Cardiothorac Surg. 2024; 19(1): 279.
- Oo AY, Loubani M, Gerdisch MW, et al. On-X aortic valve replacement patients treated with low-dose warfarin and low-dose aspirin. Eur J Cardiothorac Surg. 2024; 65(5): ezae117.
- Pardo Sanz A, Zamorano Gómez JL. How to improve patient outcomes following TAVI in 2024? Recent advances. Kardiol Pol. 2024; 82(7-8): 696–701.
